Race, ethnicity, and clinical outcomes in hormone receptor-positive, human epidermal growth factor 2 negative (HER2-), node negative breast cancer in the randomized TAILORx trial: gaps in biologic and social determinants of health

Ann Transl Med. 2022 Dec;10(24):1416. doi: 10.21037/atm-2022-59.
No abstract available

Publication types

  • Editorial
  • Comment